From Phase I-IV, Covance offers operational, medical and regulatory expertise to design trials that meet your unique requirements, proactively mitigate risks, overcome common challenges and efficiently advance your NASH program.

1. BUILD A PATH TO SUCCESS
AND ACCELERATE YOUR
NASH TRIALS
WORK WITH AN
EXPERIENCED
PARTNER
4,000+
randomized, biopsy-confirmed
patients; 170,000+
Fibrosure®
test results
INFORMATIVE NASH DATA
700+ NASH study sites
in 28 countries
INSIGHT ON NASH SITES
15 NASH
trials in
EXPERIENCE TO ENSURE
EFFICIENT TRIALS
4years

2. OVERCOME CRITICAL CHALLENGES IN NASH CLINICAL TRIALS
From Phase I-IV, Covance offers operational, medical and regulatory expertise to design
trials that meet your unique requirements, proactively mitigate risks, overcome common
challenges and efficiently advance your NASH program.
The Covance Solution: Apply
real-world data to design better
screening paradigms and determine
how specific inclusion and exclusion
criteria will impact study eligibility.
Your Results: Improve your
recruitment with our data to
identify the right populations along
with our methods to reduce screen
failure rates from a historical high
of 80% to an average of 55%, with
some sites achieving as low as 30%.
High screen failure
rates hinder patient
recruitment efforts.
CHALLENGE
The Covance Solution: Draw on
our experience working with 700+
NASH study sites in 28 countries.
We know which sites can deliver
NASH patients – and which cannot.
Your Results: Reduce the number
of sites needed in your study
and improve your efficiencies by
working with the optimal number
of high-performing sites.
Finding sites that can
deliver NASH patients.
CHALLENGE
The Covance Solution: Rely on our
support to proactively manage sites
and provide medical and operational
expertise to help solve screening
and recruitment issues as they arise
– and ensure the requirements of
your protocol are fully understood.
Your Results: When you work
with a CRO that has randomized
more NASH patients than any
other CRO, you benefit from our
key relationships to accelerate site
activation. As your partner, we
can help you reach your patient
recruitment goals – on time and
on budget.
Lack of site
engagement impacts
a trial’s timeline.
CHALLENGE
Disclaimer: Covance is the drug, medical device and diagnostics business segment of LabCorp, a leading global life sciences
company. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
© Copyright 2019 Covance Inc.
INFCVMER001-1019